(Q44412319)

English

Triple oral antidiabetic therapy

scientific article published in November 1998

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9877464

retrieved

2 December 2017

title

Triple oral antidiabetic therapy (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2 December 2017

Kaye TB

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9877464

retrieved

2 December 2017

publication date

1 November 1998

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9877464

retrieved

2 December 2017

published in

Journal of Diabetes and its Complications

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9877464

retrieved

2 December 2017

volume

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9877464

retrieved

2 December 2017

issue

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9877464

retrieved

2 December 2017

page(s)

311-313

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9877464

retrieved

2 December 2017

cites work

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1056-8727%2898%2900013-0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1056-8727%2898%2900013-0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1056-8727%2898%2900013-0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of combination therapy of troglitazone and sulphonylureas in patients with Type 2 diabetes who were poorly controlled by sulphonylurea therapy alone.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1056-8727%2898%2900013-0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperglycemia and microvascular and macrovascular disease in diabetes

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1056-8727%2898%2900013-0

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1016/S1056-8727(98)00013-0

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9877464

retrieved

2 December 2017

PubMed publication ID

9877464

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9877464

retrieved

2 December 2017

(Q44412319)

Triple oral antidiabetic therapy

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)